Fachliteratur Gastroenterologie: Neoplasien der Gallenwege

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Gallenwege » Neoplasie

22. Februar 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Fachliteratursuche

Gallenwege

Cholezystitis - Cholelithiasis

Schrift:

Seite 1 von 856


	Artikel 1 - 20 / 17114

	Outcome of resectable distal cholangiocarcinoma in a single-centre Western patient cohort: comparison of the 7th and 8th edition of the UICC/AJCC TNM classification. Acta Oncol Holm MB, Busund S, Rihel R, Sahakyan MA, Gladhaug IP, Verbeke CS, Yaqub S, Kleive D. PMID: 41711495 [PubMed - indexed for MEDLINE]
	Prognostic value of cGAS-STING-IRF3 signaling in cholangiocarcinoma patients. PLoS One Artbua P, Kentachalee N, Sitthirak S, Sa-Ngiamwibool P, Wichian P, Deenonpoe R. PMID: 41706744 [PubMed - indexed for MEDLINE]
	Twenty-year temporal trends, risk profiles, and prognostic value of clinicopathological features in gallbladder cancer following cholecystectomy. World J Gastroenterol An J, Ahn SH, Kim KH, Heo JY, Yeo MK. PMID: 41694497 [PubMed - indexed for MEDLINE]
	Gallbladder carcinoma in Brazil: Clinicopathological profile and survival outcomes from a high-volume cancer center. World J Gastroenterol Makdissi FF, Kawakami LE, Pereira MA, Kruguer JAP, Marques GF, Coelho FF, Jukemura J, Herman P. PMID: 41694496 [PubMed - indexed for MEDLINE]
	Lactate metabolism-driven tumor heterogeneity and molecular signatures in intrahepatic cholangiocarcinoma. World J Gastroenterol Wu AK, Li JY, Zhang K, Meng M, Wang X, Liu Y, Xie P, Rong WQ, Wu F, Wang HG, Meng X, Wu JX. PMID: 41694488 [PubMed - indexed for MEDLINE]
	Surgery vs. non-surgery for advanced cholangiocarcinoma post-conversion therapy with PD-1/PD-L1 inhibitors plus TKIs. Front Immunol Sun Z, Wang Y, Chen X, Yang L, Li O, Zhou J, Tan Z, Peng C. PMID: 41694340 [PubMed - indexed for MEDLINE]
	Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study. Transpl Int Kodali S, Connor AA, Victor DW 3rd, Abdelrahim M, Elaileh A, Patel K, Brombosz EW, Graviss EA, Nguyen DT, Xu S, Moore LW, Schwartz MR, Dhingra S, Basra T, Jones-Pauley MR, Noureddin M, Mobley CM, Hobeika MJ, Simon CJ, Lee Cheah Y, Heyne K, Kaseb AO, Saharia A, Gaber AO, Ghobrial RM. PMID: 41685088 [PubMed - indexed for MEDLINE]
	Rare, Yet Targetable: New Perspectives on Ampullary Carcinomas. Int J Mol Sci Gutmans J, Friedlaender A, Mechahougui H. PMID: 41684016 [PubMed - indexed for MEDLINE]
	Exploring the Role of Extracellular Vesicles in Pancreatic and Hepatobiliary Cancers: Advances Through Artificial Intelligence. Int J Mol Sci Trifylli EM, Angelakis A, Fortis SP, Kriebardis AG, Papadopoulos N, Koustas E, Sarantis P, Karamouzis MV, Manolakopoulos S, Deutsch M. PMID: 41683945 [PubMed - indexed for MEDLINE]
	Efficacy and safety of pembrolizumab, lenvatinib, and reduced-dose gemcitabine/oxaliplatin as initial treatment for advanced biliary tract cancer: a multicenter, single-arm, prospective, phase II study. J Immunother Cancer Piao M, Li C, Li S, Zhang N, Li J, Luo X, Liu R, Wang F, Shi X, Liu C, Tan G, Zhu Z, Yang X, Zhao H. PMID: 41667152 [PubMed - indexed for MEDLINE]
	How I Do It: Systemic Therapies for Primary Liver Cancers. Radiology Kim TH, Harding JJ, Chernyak V, Mendiratta-Lala M, Lee JM, Do RKG. PMID: 41665497 [PubMed - indexed for MEDLINE]
	Emergence of Liquid Biopsy in Precision Oncology: A Review of its diagnostic, Predictive and Therapeutic Applications in Gallbladder Cancer. J Gastrointest Cancer Das D, Dixit R, Pandey M. PMID: 41649626 [PubMed - indexed for MEDLINE]
	Development of A Risk Assessment Model for Venous Thromboembolism among Patients with Cholangiocarcinoma. Clin Appl Thromb Hemost Niprapan P, Phinyo P, Lapisatepun W, Charoentum C, Tantiworawit A, Punnachet T, Hantrakun N, Piriyakhuntorn P, Hantrakool S, Rattanathammethee T, Rattarittamrong E, Norasetthada L, Chai-Adisaksopha C. PMID: 41632584 [PubMed - indexed for MEDLINE]
	Prognostic impact of individual resection and dissection margins in resected perihilar cholangiocarcinoma: retrospective study. BJS Open Ten Haaft BHEA, Ahmad Al-Saffar H, Roos E, Ali M, Klümpen HJ, Nooijen L, Franken L, Kazemier G, Fernandez Moro C, Verheij J, Erdmann JI, Sturesson C. PMID: 41632543 [PubMed - indexed for MEDLINE]
	Impact of Obstructive Jaundice and Socioeconomic Determinants on Outcomes in Gallbladder Cancer: A Prospective Cohort Study. J Gastrointest Cancer Vineet K, Tripathi M, Vadodaria DR, Kumar C, Khanna D. PMID: 41617936 [PubMed - indexed for MEDLINE]
	Clinical Relevance of the CALLY Index in Prognostic Stratification of Intrahepatic Cholangiocarcinoma. Anticancer Res Matsui S, Kato Y, Ohgi K, Ashida R, Otsuka S, Dei H, Uesaka K, Sugiura T. PMID: 41617451 [PubMed - indexed for MEDLINE]
	Prognostic Factors and the Impact of Adjuvant S-1 Chemotherapy in Resected Ampulla of Vater Carcinoma: A Single-institution Retrospective Study. Anticancer Res Imamura H, Adachi T, Hamada T, Migita K, Satoh A, Kurotaki K, Nakamura S, Ogawa S, Askeyev B, Matsushima H, Kinoshita A, Soyama A, Eguchi S. PMID: 41617443 [PubMed - indexed for MEDLINE]
	Ferroptosis in Cholangiocarcinoma Therapy: Molecular Mechanisms, Pharmacological Modulation and Opportunities for Drug Development. Drug Dev Res Athar H, Zulfiqar S, Ali A, Armaghan M, Khan K, Setzer WN, Sharifi-Rad J, Calina D. PMID: 41614243 [PubMed - indexed for MEDLINE]
	Preliminary Application of Toripalimab in Combination With GEMOX Regimen as a First-Line Treatment Option for Advanced Biliary Tract Tumors. Br J Hosp Med (Lond) Yuan M, Fang W, Liu B, Tong Y, Cheng J, Zhong H, Lv W. PMID: 41609163 [PubMed - indexed for MEDLINE]
	Deep learning-based multimodal approach for non-invasive prediction and prognostic analysis of immune and angiogenic biomarkers in extrahepatic cholangiocarcinoma. Front Immunol Liu J, Cheng Z, Yang R, Fan Y, Shu Y, Tang Y, Shu J. PMID: 41607783 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 17114

Seite 1 von 856



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung